Biohaven Pharmaceutical (BHVN) had the highest return in October 2022 by a mid-cap US stock, returning 159.3%.
Biohaven Pharmaceutical (BHVN) had the highest return in October 2022 by a mid-cap US stock, returning 159.3%.
Mid-cap stocks are treated as having a market cap between $2B and $10B.